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Fragmentation and Dispersal of the
Pericentriolar Golgi Complex Is Required
for Entry into Mitosis in Mammalian Cells
been shown that these small Golgi fragments undergo
fragmentation into small vesicles or fuse with the ER
(Kano et al., 2000; Shima et al., 1997; Zaal et al., 1999).
Based on published results it is generally accepted that
Golgi fragmentation occurs in at least two sequential
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i de la Salud (2) these fragments either undergo further vesiculation or
fuse with the ER (Nelson, 2000; Rossanese and Glick, 2001).Servei de Microscopia Confocal
Universitat Pompeu Fabra Independent of the exact fate of Golgi membranes
during mitosis, there are two issues regarding the GolgiBarcelona 08003
Spain apparatus that have gone completely unnoticed. (1) Why
are Golgi membranes anchored to the pericentriolar re-
gion in mammalian cells; and (2) why do these mem-
branes undergo fragmentation and dispersal away fromSummary
the pericentriolar region during mitosis? We have ad-
dressed these questions by asking what will happenThe pericentriolar Golgi stacks are fragmented and
found dispersed in mitotic mammalian cells. Addi- to cells in which fragmentation and dispersal of Golgi
membranes are prevented at the onset of mitosis. It istion of an antibody to the Golgi-associated protein
GRASP65 inhibited Golgi fragmentation by mitotic cy- conceivable that if the reorganization of Golgi mem-
branes is prevented, cells enter mitosis and only onetosol in permeabilized cells. Microinjecting this anti-
body or the C-terminal fragment of GRASP65, which daughter cell inherits the Golgi membranes. The other
cell either dies or generates Golgi membranes de novo.contains the antibody binding site, into normal rat kid-
ney cells prevented entry into mitosis. Under these It is, however, also possible that cells do not enter mito-
sis if their Golgi membranes cannot be fragmented.conditions the cells had completed S phase but were
not in the prophase stage of mitosis. Fragmentation To address these issues, we searched for a reagent
that blocks mitotic Golgi fragmentation but which byof the Golgi apparatus by nocodazole or Brefeldin A
treatment prior to or post microinjection of the anti- itself is not essential for regulating entry into mitosis.
Protein kinases such as MEK1 or Plk are therefore notGRASP65 antibody alleviated the block in mitotic en-
try. Based on our findings, we suggest that the peri- suitable candidates. Our previous findings suggested
that GRASP65 could be involved in the process of mi-centriolar Golgi organization is a sensor for controlling
entry into mitosis in mammalian cells. totic Golgi fragmentation either directly or through inter-
action with a hitherto unidentified binding partner. We
therefore decided to generate GRASP65-specific re-Introduction
agents (an affinity-purified antibody and a GRASP65
fragment that contains the antibody binding site) to ad-The Golgi apparatus of mammalian cells is organized
into stacks of cisternae. Each stack contains an average dress the connection between Golgi fragmentation and
mitosis. We have found that the addition of theseof 4–8 cisternae, and about 40–80 such stacks are
attached to each other and anchored in the pericentrio- GRASP65-specific reagents inhibited mitosis-specific
Golgi fragmentation both in permeabilized and intactlar region. When mammalian cells enter mitosis, the peri-
centriolar stacks of Golgi cisternae undergo extensive cells. Most interestingly, inhibition of Golgi fragmenta-
tion using GRASP65-specific reagents prevented entryfragmentation, and the fragments are dispersed
throughout the cytosol. This process is mediated by of cells into mitosis. Under these conditions, the cells
have completed S phase but are not in the prophasemitogen-activated protein kinase kinase 1 (MEK1) and
Polo-like kinase (Acharya et al., 1998; Su¨tterlin et al., stage of the mitotic cycle. The significance of our find-
ings with regards to Golgi fragmentation and the regula-2001). A monophosphorylated form of ERK (pY-ERK) has
been suggested as MEK1 effector on Golgi membranes tion of entry into mitosis are discussed.
(Cha and Shapiro, 2001). Furthermore, the putative
Golgi-stacking protein GRASP55 was recently shown to Results
be phosphorylated by the MEK1 substrate ERK2 both
in vivo and in vitro (Jesch et al., 2001). Plk, on the other Identification of GRASP65-Related Reagents
hand, phosphorylates GRASP65, which is a close rela- that Block Golgi Fragmentation
tive of GRASP55 and is required for mitotic Golgi frag- We generated a polyclonal antiserum against the full-
mentation in semiintact cells (Lin et al., 2000; Su¨tterlin length epitope-tagged and bacterially expressed GRASP65
et al., 2001). Thus, the pathways MEK1-ERK2-GRASP55 protein (Su¨tterlin et al., 2001). The crude anti-GRASP65
and Plk-GRASP65 may convert the pericentriolar Golgi serum was affinity-purified on a GRASP65 antigen col-
stacks into small fragments during mitosis. It has also umn. To test the specificity of the resulting affinity-puri-
fied antibody, we performed Western blot analysis on
either purified recombinant GRASP65 protein or total3 Correspondence: malhotra@biomail.ucsd.edu
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tact NRK cells (Acharya et al., 1998). NRK cells are per-
meabilized with digitonin, washed with 1M KCl-con-
taining buffer, and incubated with mitotic cytosol
prepared from NRK cells. After a 60 min incubation at
32C in the presence of an ATP-regenerating system,
Golgi membranes are found in the form of small punctate
structures dispersed throughout the cytoplasm (Acharya
et al., 1998). Electron microscopy analysis of these cells
revealed that the small structures are composed of tu-
bulo-reticular Golgi membranes (Colanzi et al., 2000).
We tested the effect of the affinity-purified anti-
GRASP65 antibody in this assay. Salt-washed, perme-
abilized NRK cells were incubated in the presence of
an ATP-regenerating system and interphase cytosol or
mitotic cytosol in the absence or presence of 200 g/
ml of either affinity-purified anti-GRASP65 antibody or
preimmune IgG (Figure 2A). After incubation for 60 min
at 32C, the cells were processed for fluorescence mi-
croscopy using the monoclonal anti-Giantin antibody to
analyze the Golgi organization and rhodamine-conju-
gated anti-rabbit secondary antibody to follow the fate
of the exogenously added antibodies (Figure 2A). The
exogenously added anti-GRASP65 antibody recognized
its target on the Golgi membranes (Figure 2A). The ex-
periment was quantified and revealed that in the pres-
ence of the GRASP65 antibody, approximately 30% of
the cells showed a fragmented Golgi apparatus com-
pared with 65% in incubations with preimmune IgG (Fig-
ure 2B).
Based on these experiments, we conclude that the
anti-GRASP65 antibody is a suitable reagent for inhib-
iting the fragmentation of the pericentriolar Golgi appa-
ratus by mitotic extract (Su¨tterlin et al., 2001).
Addition of the C-Terminal Region of GRASP65
Blocks Mitotic Golgi Fragmentation
The N-terminal portion of GRASP65 contains both theFigure 1. The GRASP65 Antibody Recognizes a Single Polypeptide
in NRK Cell Extracts Plk binding site (amino acids 7–120) as well as the
GM130 binding site (amino acids 189–201) (Figure 3A;(A) A construct encoding the epitope-tagged full-length GRASP65
(N-terminal 6 Histidine tag and C-terminal Flag tag) was expressed Barr et al., 1997; Lin et al., 2000). We first mapped the
in bacteria, and the recombinant protein was purified by affinity domain within GRASP65 that is recognized by the affin-
chromatography on a Nickel-agarose column. The pure protein ity-purified anti-GRASP65 antibody. Various deletion con-
shown in lane 1 was used for immunization of rabbits. Preimmune
structs of GRASP65 were generated, and the recombinantserum and affinity-purified antiserum were tested for specificity by
epitope-tagged proteins were expressed in E. coli, puri-Western blotting on either purified recombinant protein (lanes 2 and
fied, and analyzed by SDS-PAGE followed by Western4) or total NRK lysate (lanes 3 and 5).
(B) Preimmune or affinity-purified anti-GRASP65 antibodies was blotting (Figure 3B). We observed that, in contrast to
tested by immunofluorescence microscopy of NRK cells. The preim- the anti-Flag antibody, which recognized all fragments,
mune serum does not show any specific staining. The anti-GRASP65 the binding sites of the affinity-purified anti-GRASP65
antibody recognizes the Golgi apparatus as determined by costain-
antibody is located predominantly in the C-terminal re-ing with a bona fide Golgi protein, Giantin.
gion of GRASP65 (Figure 3B). GRASP65200 does not
contain the Plk and GM130 binding sites. We tested
the effect of GRASP65200 in the Golgi fragmentationNRK cell lysates (Figure 1A). We found that the antise-
process. The permeabilized cell system mentionedrum, in contrast to the preimmune IgG, recognizes pico-
above was incubated with 100 g/ml of the C-terminalgram amounts of recombinant protein and a single poly-
region of GRASP65 (GRASP65200) for 60 min at 32C,peptide of 65 kDa in total NRK cell lysates. As expected,
and the organization of the Golgi apparatus was moni-epitope-tagged, recombinant GRASP65 migrates slightly
tored by fluorescence microscopy using the anti-Giantinhigher on SDS-polyacrylamide gels than the endoge-
monoclonal antibody (data not shown). Quantitation ofnous GRASP65 from NRK cells (Figure 1A, lanes 4 and
the assay revealed that, in the presence of the C-terminal5). Immunofluorescence microscopy of NRK cells with
GRASP65 fragment, Golgi breakdown occurred in 30%the affinity-purified antibody and not the preimmune IgG
of the cells, in contrast to 70% in control cells lackingrevealed staining of the Golgi apparatus (Figure 1B).
We have reconstituted Golgi fragmentation in semiin- the GRASP65 fragment (Figure 3C).
Regulation of Entry into Mitosis by the Golgi
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Thus, the affinity-purified anti-GRASP65 antibody and
GRASP65200 inhibit Golgi fragmentation during mito-
sis without inhibiting and/or sequestering Plk and GM130.
Golgi Fragmentation Is Necessary for Entry
into Mitosis in Intact Mammalian Cells
NRK cells were arrested in S phase by aphidicolin treat-
ment. The cells were washed to remove aphidicolin, and
at various time points after aphidicolin washout, they
were stained with anti-phospho Histone H3 antibody,
anti-Giantin antibody, and with the DNA-specific dye
Hoechst 33342. We count a random population of 400
cells and determine how many cells have mitotic DNA
and a fragmented Golgi apparatus. The number of cells
in mitosis increases with time and reaches a peak of 80
at 7.5 hr after aphidicolin washout. The numbers then
drop to about 13 by 9.5 hr postaphidicolin washout (Fig-
ure 4A; numbers shown are an average of two indepen-
dent experiments). Mitotic cells round up and it is diffi-
cult to keep these cells attached to the coverslip,
especially during the procedures for fluorescence mi-
croscopy. For all the experiments described below, we
incubate cells for 7.5 hr after aphidicolin washout be-
cause at this time point the number of mitotic cells was
the highest.
NRK cells were arrested in S phase with aphidicolin,
washed to remove aphidicolin, and after 45 min of incu-
bation in regular cell culture medium, 400 cells per cov-
erslip were microinjected with either affinity-purified
anti-GRASP65 antibody or preimmune IgG. At 7.5 hr
after release from the S phase block, the cells were fixed
and processed for immunofluorescence microscopy.
Rhodamine-conjugated anti-rabbit IgG was used to de-
tect antibody-injected cells. The organization of the
Golgi membranes and the DNA was monitored by stain-
ing with the anti-Giantin antibody and Hoechst 33342,
respectively. The cells were also stained with anti-phos-
pho Histone H3 antibody (Figure 4B). Histone H3 is phos-
phorylated in early prophase and is thus a good marker
for identifying cells in prophase and the postprophase
mitotic stages (Cheung et al., 2000). Out of a population
of 400 cells injected with the preimmune IgG, 74  4
cells were in mitosis as judged by condensed DNA,Figure 2. Anti-GRASP65 Antibody Inhibits Mitosis-Specific Golgi
staining with anti-phospho Histone H3 antibody, andFragmentation in Permeabilized Cells
fragmented Golgi membranes. This number is very simi-(A) NRK cells were grown on coverslips and treated with 2 mM
lar to the number of mitotic cells found in noninjectedthymidine for 8–12 hr. The cells were subsequently permeabilized,
washed with 1 M KCl-containing buffer, and incubated with 7 mg/ control cells on the same coverslips (Figure 4C). There-
ml mitotic extract in the absence or presence of 200 g/ml affinity- fore, the antibody injection procedure per se does not
purified preimmune IgG or anti-GRASP65 antibody. After a 60 min have any effect on the ability of cells to enter mitosis.
incubation at 32C, cells were fixed and processed for immunofluo-
In contrast, out of a population of 400 cells injected withrescence using an anti-Giantin antibody (Giantin) to stain Golgi
the anti-GRASP65 antibody, only 34  12 cells had amembranes and rhodamine-conjugated anti-rabbit IgG (rabbit IgG)
fragmented Golgi apparatus and mitotic DNA (Figure 4C).to visualize the localization of the anti-GRASP65 antibody or the
preimmune IgG. The exogenously added antibody stains the same As shown above, the C-terminal region of GRASP65
membrane fragments as the anti-Giantin antibody, suggesting that inhibits the mitosis-specific fragmentation of the Golgi ap-
it recognizes its target protein on Golgi membranes. The presence paratus in our semiintact cell assay (Figure 3C). We tested
of the anti-GRASP65 antibody inhibits fragmentation of the pericen-
the effect of this peptide on Golgi fragmentation in intacttriolar Golgi apparatus.
mammalian cells. The experimental protocol to test the(B) The percentage of cells with fragmented Golgi after incubation
involvement of the C-terminal region of GRASP65 wasof cells with mitotic extract containing either PBS, preimmune se-
rum, or anti-GRASP65 antibody is shown. The data represent the precisely the same as that described for the affinity-puri-
average of four independent experiments. fied anti-GRASP65 antibody. NRK cells were treated with
aphidicolin to arrest cells in S phase. The cells were
washed to remove aphidicolin, and approximately 400
cells/coverslip were microinjected with GRASP65200. At
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Figure 3. The C-Terminal Portion of
GRASP65 Is Recognized by the Affinity-Puri-
fied Anti-GRASP65 Antibody and Inhibits Mi-
totic Golgi Fragmentation in Semiintact Cells
(A) A schematic drawing of the recombinant
full-length GRASP65 protein (FL) and the
fragments (1–204, 200) used in this study.
All constructs contain an N-terminal 6 Histi-
dine tag (6His) and a C-terminal Flag tag
(Flag). The known binding sites for Plk (amino
acids 7–120) and GM130 (amino acids 189–
201) are indicated.
(B) Recombinant full-length GRASP65 (FL),
the N-terminal fragment (1–204), and the
C-terminal fragment (200) were generated
in bacteria and purified on a Nickel-agarose
column. The recombinant proteins were sep-
arated by SDS-PAGE, and Western blot anal-
ysis was performed using either an antibody
to the Flag epitope or the affinity-purified anti-
GRASP65 antibody.
(C) The recombinant C-terminal portion of
GRASP65 (200) or PBS were incubated with
mitotic extract and an ATP-regenerating sys-
tem for 10 min. The mixtures were then added
to permeabilized, salt-washed NRK cells.
After a 60 min incubation at 32C, cells were
fixed and processed for immunofluorescence
using anti-Giantin antibody to visualize the
morphology of the Golgi. The percentage of
cells with fragmented Golgi membranes in
four independent experiments are shown.
7.5 hr after release from the S phase block and incuba- and pericentrin antibody (data not shown; Hinchcliffe
and Sluder, 2001).tion in complete medium, cells were fixed and stained
for immunofluorescence microscopy. We observed that To test whether the GRASP65 antibody-mediated ef-
fect on entry into mitosis represents a delay or a blockmicroinjection of GRASP65200 lowered the number of
mitotic cells from 80  10 out of a population of 400 of entry into mitosis, the following experiment was car-
ried out. Noninjected control and anti-GRASP65 IgG-noninjected control cells to 38  5. A similar experiment
was carried out with anti-GRASP65 antibody that was injected cells were stained with DNA- and Golgi-specific
reagents (described above) at various times after aphidi-affinity purified against GRASP65200. The cells were
microinjected with this particular antibody, and it was colin washout. For each time point, 400 cells were
counted. In control cells, the number of cells with mitoticfound to inhibit Golgi fragmentation and entry into mito-
sis in greater than 55% of the cells (data not shown). DNA and fragmented Golgi dropped from 80 at 7.5 hr
to 42 at 8.5 hr and finally to 13 at 9.5 hr after aphidicolinThus, the injection of anti-GRASP65 affinity-purified IgG
or the GRASP65200 peptide inhibits entry into mitosis removal. In anti-GRASP65 IgG-injected cells, the num-
ber of cells with mitotic DNA and fragmented Golgi wasin 50%–55% of the injected cells. Injection of the anti-
GRASP65 antibody did not affect the actin and microtu- approximately 40 after 6.5–8.5 hr and dropped to 18 at
9.5 hr after aphidicolin washout (Figure 4E; data shownbule cytoskeleton (data not shown). Also, the duplication
and separation of centrioles appeared normal as moni- is an average of two independent experiments). In other
words, while there is a sharp drop in the number oftored by staining of noninjected control and anti-
GRASP65 IgG-injected cells with anti--tubulin antibody mitotic cells in noninjected control cells, the number
Regulation of Entry into Mitosis by the Golgi
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Figure 4. Microinjection of the Affinity-Purified Anti-GRASP65 Antibody or of the Recombinant C-Terminal Portion of GRASP65 Blocks Entry
into Mitosis
(A) NRK cells were arrested in S phase with aphidicolin. The cells were washed to remove aphidicolin and at various times were stained with
Golgi- and DNA-specific markers. The number of cells showing condensed DNA, phospho-Histone H3 antibody staining, and fragmented
Golgi are shown. For each time point, 400 cells were counted. The number of cells showing these mitotic features is 80 at 7.5 hr and drops
to 13 by 9.5 hr after aphidicolin washout. The data shown is an average of two independent experiments.
(B) NRK cells grown on coverslips were treated with aphidicolin for 12–16 hr. Aphidicolin was removed 45 min prior to microinjection of
either preimmune IgG or affinity-purified anti-GRASP65 IgG. At 7.5 hr after aphidicolin washout, the cells were fixed and processed for
immunofluorescence using rhodamine-conjugated anti-rabbit IgG to stain for injected cells, a monoclonal antibody to stain the medial Golgi
marker Giantin, and the Hoechst 33342 DNA dye and the anti-phospho Histone H3 antibody to visualize the state of DNA. The cells injected
with the preimmune IgG show a fragmented Golgi. These cells enter mitosis as revealed by staining with the Hoechst dye (a–d) and reactivity
with the phospho-Histone H3 antibody (a–d). Cells injected with the anti-GRASP65 IgG contain an intact Golgi apparatus in the pericentriolar
region. The staining with Hoechst (e–h) reveals that the DNA is uncondensed and there is no staining with the anti-phospho Histone H3
antibody (e–h). Since phosphorylation of Histone H3 is a hallmark of mitotic events beginning in prophase, these results reveal that the anti-
GRASP65 IgG-injected cells have not reached the prophase stage of the mitotic cycle.
(C) Following the injection protocol described for (B), 400 noninjected control cells or cells that had been microinjected with either preimmune
IgG or affinity-purified anti-GRASP65 antibody were analyzed for the organization of the DNA and the Golgi apparatus. The quantitation shows
the values obtained from six independent experiments.
(D) The C-terminal portion of GRASP65 (GRASP65200) was microinjected into NRK cells 45 min after their release from an aphidicolin block.
FITC-Dextran was coinjected with the recombinant protein to facilitate the visualization of injected cells. Cells were left in complete medium
for 7.5 hr after aphidicolin washout. The cells were fixed and processed for immunofluorescence microscopy. The Hoechst DNA dye was
used to visualize the state of DNA in either noninjected control cells or cells microinjected with the GRASP65200 protein. For each condition,
400 cells were counted; the values shown are derived from three independent experiments.
(E) Noninjected control cells and anti-GRASP65 IgG-injected cells were stained with the DNA dye and Golgi markers after removal of aphidicolin.
The number of cells with mitotic DNA and fragmented Golgi drops from 80 at 7.5 hr to 13 by 9.5 hr in a population of 400 noninjected control
cells. In cells injected with the anti-GRASP65 antibody, the number of cells with mitotic DNA and fragmented Golgi remains at about 40 at
6.5–8.5 hr and drops to 18 at 9.5 hr after aphidicolin removal. The data shown is an average of two independent experiments.
of mitotic cells in a population injected with the anti- into mitosis. If there had been a kinetic delay in the entry
into mitosis, there should have been an increase in theGRASP65 IgG remains at a 50% level during this entire
time period (Figure 4E). These results demonstrate that number of cells with fragmented Golgi and condensed
DNA in the anti-GRASP65 antibody-injected cells at thea block in Golgi fragmentation causes a block in entry
Cell
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Figure 5. Prefragmentation of the Pericentri-
olar Golgi Apparatus Prior to Microinjection of
the Antibody Abolishes the Cell Cycle Arrest
(A) NRK grown on coverslips were arrested in
S phase with aphidicolin for 12–16 hr. Cells
were washed to remove aphidicolin and placed
in fresh medium containing 500 ng/ml nocoda-
zole. After 90 min of treatment with nocodazole,
400 cells/coverslip were microinjected with af-
finity-purified anti-GRASP65 antibody. The
cells that were left in complete tissue culture
medium in the presence of nocodazole were
fixed 7.5 hr after aphidicolin washout and pro-
cessed for immunofluorescence microscopy
using rhodamine-conjugated anti-rabbit IgG
to detect injected cells and using anti-Giantin
antibody to visualize the morphology of the
Golgi apparatus. Cells were also stained with
the Hoechst DNA dye. These cells enter the
normal mitotic cycle as shown by the pres-
ence of cells in the early (top images) and the
late stages (bottom images) of mitosis.
(B) Following the procedure for nocodazole
treatment and injection of the anti-GRASP65
antibody, 400 cells were counted for each of
the experimental conditions to determine the
number of cells containing mitotic DNA/Golgi
features. Treatment with nocodazole allevi-
ates the anti-GRASP65 IgG-induced inhibi-
tion of entry into mitosis. The results shown
are derived from four independent experi-
ments.
8.5–9.5 hr window of this experiment. Thus, injection of zole, the cells were fixed and processed for fluorescence
microscopy as described above. In cells pretreated withGRASP65 IgG prevents entry into mitosis as evident
from the findings that the cells do not contain condensed nocodazole and microinjected with the affinity-purified
anti-GRASP65 IgG, the Golgi apparatus appears asDNA nor stain with the anti-phospho Histone H3 anti-
body, which is a hallmark of the onset of the prophase small fragments dispersed throughout the cell (Figure
5A). While in the absence of nocodazole, injection ofstage of the mitotic cycle.
anti-GRASP65 IgG caused a drop in the number of mi-
totic cells from 80  10 to 34  12 out of a populationFragmentation and Dispersal of the Golgi
Apparatus Alleviates the Inhibition of 400 cells; the number of cells with mitotic DNA was
75  8 in the presence of nocodazole. Thus, if Golgiof Entry into Mitosis
Microtubule-depolymerizing agent nocodazole causes membranes are fragmented with nocodazole prior to
injection of anti-GRASP65 IgG, the anti-GRASP65 anti-the fragmentation of the pericentriolar Golgi apparatus.
As a result of this treatment, Golgi membranes are found body does not block entry of cells into mitosis.
In another approach, we asked what happens if thein the form of small stacks dispersed throughout the
cell (Cole et al., 1996). NRK cells were treated with cells are injected with the anti-GRASP65 antibody to
inhibit Golgi fragmentation followed by fragmentationaphidicolin to arrest cells in S phase. Aphidicolin was
removed and the cells were treated with 500 ng/ml noco- of the Golgi membranes by artificial means. Would this
treatment affect entry of cells into mitosis? Treatmentdazole for 90 min prior to injection with the affinity-
purified anti-GRASP65 antibody. After 6 additional hours of cells with nocodazole depolymerizes microtubules
and causes the Golgi stacks to dissociate from eachof incubation in complete medium containing nocoda-
Regulation of Entry into Mitosis by the Golgi
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Figure 6. Fragmentation of the Pericentriolar
Golgi Apparatus after Microinjection of Anti-
GRASP65 IgG Abolished the Cell Cycle Arrest
NRK cells grown on coverslips were arrested
in S phase with aphidicolin for 12–16 hr. Cells
were washed to remove the aphidicolin and
placed in fresh medium for 45 min. The cells
were then injected with the anti-GRASP65 an-
tibody. A control is included that represents
noninjected control cells on the same cover-
slips. After 3.75 hr of incubation after aphidi-
colin removal, the cells was either left un-
treated or they were treated with Brefeldin A
(BFA) or nocodazole for an additional 3 hr.
The cells were then fixed and processed for immunofluorescence microscopy using rhodamine-conjugated anti-rabbit IgG to detect injected
cells and using anti-Giantin antibody to visualize the morphology of the Golgi apparatus. Cells were also stained with the Hoechst DNA dye
and anti-phospho Histone H3 antibody. The number of cells with mitotic DNA was determined as described in Figure 4A. Injection of the anti-
GRASP65 antibody inhibits entry into mitosis, whereas the fragmentation of the pericentriolar Golgi apparatus with BFA or nocodazole alleviates
the antibody-mediated inhibition of entry into mitosis. The data presented are average values from two independent experiments.
other; the stacks are then found dispersed away from microinjected with the anti-GRASP65 antibody. After 7.5
hr of incubation, the cells were fixed and processed forthe pericentriolar region (Cole et al., 1996). Treatment
with Brefeldin A (BFA) causes Golgi membranes to fuse fluorescence microscopy to monitor the organization of
the Golgi apparatus and the DNA. The number of cellswith the ER (Lippincott-Schwartz et al., 1989). NRK cells
were arrested in S phase by treatment with aphidicolin. with mitotic feature out of a population of 400 cells is 36
(with or without caffeine treatment), compared with 80Aphidicolin was removed, and 45 min later the cells were
injected with the anti-GRASP65 antibody. At 4.5 hr after mitotic cells in the population of noninjected control cells
on the same coverslip (Figure 7; data shown is an averagerelease from the aphidicolin block, the cells were treated
with either nocodazole or BFA for 3 hr (Figure 6). The of two independent experiments). Similarly, the block in
entry into mitosis by injection of the GRASP65200 pep-concentrations of these drugs fragment the Golgi appa-
ratus without any effect on the ability to enter mitosis tide was not alleviated by caffeine treatment (data not
shown). Our findings reveal that pretreating cells with(data not shown). The cells were then fixed and pro-
cessed for fluorescence microscopy to visualize the or-
ganization of the Golgi apparatus and the DNA. As de-
scribed before, out of a population of 400 cells, the
number of cells with mitotic DNA was 80. Injection of
the anti-GRASP65 antibody lowered this number to 34.
However, in cells that had been injected with the anti-
GRASP65 antibody followed by nocodazole or BFA
treatment, mitotic features were found in 80 and 78 cells,
respectively (Figure 6). In other words, fragmentation of
the Golgi apparatus with nocodazole or BFA alleviated
the anti-GRASP65 IgG-mediated inhibition of Golgi frag-
mentation and block of entry into mitosis.
The Block in Mitosis by Inhibition of Golgi
Fragmentation Does Not Activate the DNA
Damage Checkpoint Machinery
A defect in replication or artificially induced DNA dam-
age by UV irradiation activates a set of components
that arrest cells at the G2/M transition. The ATM (ataxia
telangiectasia-mutated) family members are the key
players in this DNA damage checkpoint, and they act
Figure 7. The Inhibition in Entry into Mitosis Is Not Due to Defectiveby regulating Chk1 and 2, the cdc25 phosphatase and
Replication or the Activation of DNA Damage Checkpoint
cdc2 (Abraham, 2001). Activation of the ATM pathway
NRK cells were arrested in S phase with aphidicolin treatment. Theinhibits entry into mitosis, and this inhibition is alleviated
cells were washed to remove aphidicolin and then treated with 2
by treating cells with caffeine (Zhou et al., 2000). To test mM caffeine. At 45 min after removal of aphidicolin and addition
whether cells injected with the anti-GRASP65 antibody of caffeine, the cells were microinjected with the anti-GRASP65
antibody. After 7.5 hr of incubation in complete tissue culture me-activate the ATM pathway and are therefore arrested at
dium containing caffeine, the cells were fixed and processed forthe G2/M transition, the following experiment was car-
immunofluorescence as described above. The number of cells inried out. NRK cells were treated with aphidicolin to block
mitosis does not change significantly upon treatment with caffeine.cells in S phase. The cells were washed to remove
Therefore, caffeine treatment does not override the block in entry
aphidicolin and incubated with 2 mM caffeine to prevent into mitosis induced by a lack of the fragmentation of the pericentrio-
the activation of the ATM pathway. At 45 min after lar Golgi apparatus. The data presented are average values from
two independent experiments.aphidicolin washout and caffeine addition, the cells were
Cell
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Figure 8. Inhibition in the Fragmentation of
the Pericentriolar Golgi Apparatus Does Not
Affect DNA Replication and the Completion
of S Phase
(A) NRK cells were arrested in S phase with
aphidicolin treatment. The cells were washed
to remove aphidicolin and microinjected with
the anti-GRASP65 antibody. Sixty minutes
later, the cells were pulse-labeled for 30 min
with 15 M BrdU. The cells were fixed after
6 hr and processed for fluorescence micros-
copy to visualize injected cells, the organiza-
tion of the Golgi, and the DNA. The nonin-
jected control cells revealed BrdU staining of
the different stages post aphidicolin removal
([a] S/post S phase, [b] prophase, [c] meta-
phase, [d] anaphase/telophase). The cells
that are injected with the anti-GRASP65 IgG
reveal BrdU incorporation into the DNA; how-
ever, these cells are not in any of the mitotic
stages (e–h). Thus, BrdU uptake is not
blocked by anti-GRASP65 IgG injection, but
the progression into the mitotic cycle is
blocked.
(B) NRK cells were arrested in S phase by
aphidicolin treatment. Noninjected control
cells and the anti-GRASP65 IgG-injected
cells were maintained in aphidicolin for 7.5
hr. In a parallel experiment, the cells were
washed to remove aphidicolin and injected
with anti-GRASP65 IgG. After 7.5 hr of incu-
bation, the coverslips were stained with anti-
Cyclin E antibody. The results reveal that in
aphidicolin-arrested cells, Cyclin E is pre-
dominantly within the nucleus (left images).
After release from the aphidicolin block, the
noninjected control cells and the anti-
GRASP65 IgG-injected cells show an ab-
sence of Cyclin E from the nucleus (right im-
ages). The presence of Cyclin E in the nucleus
is an indicator of the cells in S phase. By G2,
Cyclin E is exported from the nucleus. Our
results provide strong evidence that the anti-
GRASP65 IgG-injected cells have completed
S phase like their noninjected control coun-
terparts.
caffeine and thus inactivating the ATM-dependent DNA cells injected with the anti-GRASP65 IgG, BrdU uptake is
evident but only in the uncondensed form of DNA (Figuredamage checkpoint machinery does not override the
8A, e–h). Thus, there is no defect in BrdU uptake in cellsinhibition in entry into mitosis caused by the block in
that have been injected with GRASP65 IgG; however,Golgi fragmentation. This is a strong proof that the block
these cells are not in any of the stages of the mitoticin entry into mitosis induced by inhibition of Golgi frag-
cycle. Thus, in cells in which Golgi fragmentation wasmentation occurs by a novel pathway and is not through
inhibited by the anti-GRASP65 antibody, there is no de-the activation of the ATM family members.
fect in DNA replication.
To test whether anti-GRASP65 IgG-injected cells are
Injection of the Anti-GRASP65 Antibody Does Not arrested in S phase or after completion of S phase,
Affect Replication and Completion of S Phase the following experiment was performed. Noninjected
In an additional experiment, cells were microinjected control or anti-GRASP65 IgG-injected cells were either
with the affinity-purified anti-GRASP65 antibody 45 min maintained in aphidicolin-containing medium or incu-
after aphidicolin release. After 60 min, the cells were bated in regular medium for 7.5 hr. The cells were then
pulse labeled with 15 M BrdU (bromodeoxyuridine) stained with an anti-Cyclin E antibody. Cyclin E in S
for 30 min (Celis, 1994). Approximately 5 hr after BrdU phase-arrested cells is mostly nuclear, whereas cells
labeling, the cells were fixed and stained with a mono- that have completed S phase show a nonnuclear Cyclin
clonal antibody to BrdU-stained DNA and a rhodamine- E staining (during this transition, Cyclin E is exported
conjugated anti-rabbit secondary antibody to detect the from the nucleus and ultimately degraded) (Ohtsubo et
injected cells. In noninjected control cells, BrdU is incor- al., 1995; Yang and Kornbluth, 1999). Our results show
porated into the DNA that is uncondensed (Figure 8A, that in noninjected control and anti-GRASP65 IgG-
injected cells that are arrested in S phase, Cyclin E isa) and into early and late mitotic DNA (Figure 8A, b–d). In
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in the nucleus (Figure 8B, left images). At 7.5 hr after when the Golgi membranes are in the pericentriolar re-
gion. Once the Golgi membranes have been fragmentedaphidicolin washout, Cyclin E is nonnuclear (Figure 8B,
right images) in both noninjected control and anti- and dispersed away from the pericentriolar region, for
example, by treatment with BFA or nocodazole, theGRASP65 IgG-injected cells. Thus, the cells injected
with the anti-GRASP65 IgG have completed S phase GRASP65-specific reagents do not affect entry into mi-
tosis. Thus, the potency of GRASP65 inhibitory reagentsbut are not in the prophase stage of mitosis.
vis-a-vis entry into mitosis is only effective when the
Golgi apparatus is in the pericentriolar region. This isDiscussion
an important finding and reveals that it is the location
of the Golgi membranes and not GRASP65 itself thatIt is generally accepted that Golgi membranes in mam-
regulates entry into mitosis.malian cells fragment as a consequence of entry into
the mitotic cycle. Our findings reveal that the process
of Golgi fragmentation is initiated prior to the appear- Golgi Membranes in the Pericentriolar Region:
A Sensor for Controlling Entry into Mitosisance of these membranes in a highly fragmented form,
which is observed in the early to late metaphase stage Our finding that inhibiting Golgi fragmentation prevents
entry into mitosis is both peculiar and thought pro-of mitosis. Preventing Golgi fragmentation at this early
stage inhibits entry into mitosis. Thus, fragmentation of voking. We have ruled out the trivial possibility that this
is due to an unspecific effect of the anti-GRASP65 anti-the Golgi apparatus is not an effect of mitosis-specific
events but a key cause regulating entry of cells into body or the GRASP65200 peptide. These reagents,
when injected into cells that contain Golgi membranesmitosis. This would explain the fragmentation and the
dispersal of the pericentriolar Golgi apparatus by MEK1 distal from the pericentriolar region (as a consequence
of treatment with nocodazole or BFA, for example) doand Plk in the absence of cdc2 kinase in our mitotic Golgi
fragmentation assay in the semiintact cells (Acharya et not block entry into mitosis. The injection of the anti-
GRASP65 antibody does not affect the organization ofal., 1998; Colanzi et al., 2000; Su¨tterlin et al., 2001).
We have previously shown that the addition of microtubules and the actin cytoskeleton, thus ruling out
the possibility that defects in the cytoskeleton are pre-GRASP65 prevents Golgi fragmentation in an in vitro
assay reconstituting mitosis-specific fragmentation of venting entry into mitosis.
So why should inhibiting the fragmentation of theGolgi membranes (Su¨tterlin et al., 2001). However, we
could not rule out the possibility that this inhibition is due Golgi apparatus affect entry into mitosis? There are two
likely reasons for the block of entry into mitosis. (1)to sequestration of Plk, which phosphorylates GRASP65
and is required for mitosis-specific Golgi fragmentation Fragmentation and dispersal of Golgi fragments from
the pericentriolar region serves as a “specific trigger”by itself (Su¨tterlin et al., 2001). Here, we show that both
an affinity-purified antibody to GRASP65 as well as a for entry into mitosis. The rationale behind this scheme
is that if Golgi membranes remain in the pericentriolarC-terminal fragment of GRASP65 (GRASP65200),
which does not contain the GM130 and Plk binding sites, region and all else proceeds as normal, the cells will
duplicate and only one of the two daughter cells willprevent mitosis-specific Golgi fragmentation in vitro and
in intact cells. The most likely reason for the inhibition inherit the Golgi apparatus. The other cell devoid of the
Golgi apparatus will not be viable, especially if the cellsobserved with the anti-GRASP65 antibody and the re-
combinant protein is that they compete with a hitherto do not have the ability to generate Golgi membranes de
novo in postmitotic cells. Therefore, the cells abort entryunidentified binding partner (a kinase and/or other inter-
acting components). GRASP65 is known to interact with into the mitotic cycle. (2) The pericentriolar Golgi mem-
branes serve as a scaffold for proteins that are requiredthe Golgi protein GM130 in vitro (Barr et al., 1998). While
GM130 has been suggested to play a role in mitotic for regulating entry into mitosis. The fragmentation and
dispersal of the Golgi membranes from the pericentriolarGolgi fragmentation, others have reported that GM130
is not required for Golgi fragmentation and assembly region is necessary for the delivery/transport of these
key components to their respective sites of action. Im-during cell division in intact cells (Lowe et al., 1998;
Puthenveedu and Linstedt, 2001). Regardless of the sig- plicit in this scheme is the possibility that a component
necessary for promoting entry into mitosis is inactivenificance of the interaction between GRASP65 and
GM130, we have found that the observed anti-GRASP65 while bound to the pericentriolar Golgi membranes. The
fragmentation of Golgi membranes causes release andantibody-dependent inhibition of Golgi fragmentation in
vitro and in intact cells is not due to a block in the consequent activation of this particular component.
It is important to note that in plants, yeast, and flies,interaction between GRASP65 and GM130 (data not
shown). GRASP65 has been reported to be required for Golgi membranes are not attached to the pericentriolar
region, nor do they undergo any apparent change instacking of the Golgi cisternae in vitro (Barr et al., 1997).
However, there is also published data that GRASP65 their organization during the cell cycle (Nebenfuhr et al.,
2000; Preuss et al., 1992; Stanley et al., 1997). In con-continuously cycles on and off the Golgi membranes in
intact cells (Ward et al., 2001). It is hard to conceive trast, the Golgi membranes in mammalian cells undergo
a change from their pericentriolar nonmitotic locationhow a rapidly cycling molecule could be involved in the
stacking of the Golgi cisternae, unless of course one to a highly fragmented form in late mitotic stages. This
localized pericentriolar position of the Golgi membranespostulates that Golgi membranes are always undergoing
a process of stacking and unstacking during protein may thus be an additional evolutionary advantage to
control entry into mitosis. It is tempting to speculatetransport. Our own findings suggest a role for GRASP65
in regulating the mitosis-specific dynamics, but only that the preparation for entry into mitosis in mammalian
Cell
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GRASP65 using Nickel-agarose (Qiagen), the protein fractions werecells is governed by two distinct sets of components.
loaded onto a large preparative gel for additional purification fromOne set of components monitor the status of the DNA.
copurifying contaminants. Pure GRASP65 was then cut out of theDefects in DNA replication (or DNA damage) activates
SDS-Polyacrylamide gel and eluted from the gel slices by electroelu-
a set of components that prevent entry into mitosis by tion and used to inject rabbits. The various bleeds were tested for
keeping cdc2 kinase in an inactive form (Abraham, reactivity with recombinant protein and total NRK lysate by Western
2001). We propose the existence of a second set of blot analysis or by immunofluorescence. The anti-GRASP65 anti-
body was affinity purified as described (Harlow and Lane, 1988). Incomponents that check the status of the Golgi appara-
brief, an antigen column was generated by coupling approximatelytus. Defects in the organization of the Golgi apparatus
4 mg of recombinant full-length GRASP65 or GRASP65200 cova-is sensed by the cells and prevents them from entering
lently to activated CNBr beads (Sigma); the column was washed
mitosis. The DNA-dependent and the “pericentriolar with PBS and incubated with the crude antiserum. Immediately after
Golgi position-specific” controls operate independent elution of the antibody with 100 mM glycine (pH 2.5), the eluted
of each other. Only when both of these events are pro- sample was brought to neutral pH and dialyzed against PBS con-
taining 10% glycerol in a Slide-A-Lyzer slide (Pierce). The affinity-gressing normally are the cells allowed to enter mitosis.
purified antibody was then concentrated using Microcon spin col-In this manner the nuclear and cytoplasmic events coor-
umns (Millipore) to a final concentration of 12 mg/ml. Preimmunedinate to permit equal partitioning of the cellular machin-
IgG was purified by binding the crude preimmune serum to a Proteinery in a functional form that is necessary for growth and
A-Sepharose (Pharmacia) column. IgG was eluted with 100 mM
division of the progeny. This is a challenging proposal glycine (pH 2.5), dialyzed, and concentrated as described for the
and identifying components that confer upon the Golgi anti-GRASP antibody.
membranes the function to act as a sensor for entry into
mitosis will not be easy. But it is our hope that our in Generation of Recombinant GRASP65 Fragments
vitro assay, which is a good mimic of the situation in GRASP65 constructs were generated by PCR using a full-length
Flag-tagged cDNA construct in pBSK as template (Lin et al., 2000).living cells with regards to the initiation and subsequent
PCR fragments were generated using the following oligonucleo-fragmentation of the pericentriolarly organized Golgi
tides. Full-length, described previously in Su¨tterlin et al. (2001);membranes, will help us address this issue. The use of
1–204 (upstream primer1), 5-GGAGGCATGCGGGGCTAGGGGCAthis assay should reveal machinery that in addition to
AGCAGCGAG; 1–204 (downstream primer3), 5-GGAGAAGCTTCT
MEK1 and Plk is required for the pericentriolar Golgi ACTTGTCATCGTCGTCCTTGTAGTCCTGCGTTGGGATCCGGTG
fragmentation. These key reagents can then be put to CAG;200 (upstream primer 3), 5-GGAGGCATGCCCGGATCCCAA
test in intact cells to address the loftier proposal of “how CGCAGCCCTCC;200 (downstream primer 1), Su¨tterlin et al. (2001).
These PCR products were subcloned into the SphI and HindIII re-and why” the Golgi apparatus of the mammalian cells
striction sites of the pQE31 bacterial expression vector (Qiagen).acts as a sensor in regulating entry into mitosis.
Recombinant proteins were obtained by expression in bacteria and
subsequent purification using Ni-agarose. Purified proteins wereExperimental Procedures
concentrated using Microcon spin columns (Millipore) and dialyzed
against KHM, 5% glycerol. It is important to note that all recombinantReagents
proteins were purified in the absence of detergent.The following antibodies were used in this study: anti-Giantin (Mal-
hotra lab), anti--tubulin, anti-Flag epitope (Sigma), anti--tubulin
(Accurate Chemicals & Scientific Corp.), anti-BrdU (Calbiochem), Microinjections
anti-phospho-histone H3 (kindly provided by Dr. Kevin Sullivan, Anti-GRASP65 antibody that was affinity purified to either full-length
Scipps Research Institute, La Jolla), anti-Pericentrin (Covance), and or to GRASP65200 recombinant protein or preimmune IgG, all at
anti-Cyclin E (kindly provided by the Newport lab, UCSD). Rhoda- a concentration of 12 mg/ml, were injected into approximately 400
mine-conjugated Phalloidin and Hoechst 33342 were from Molecular aphidicolin-arrested NRK cells (aphidicolin was used at 2.5 g/ml)
Probes. 45 min after removal of the S phase block. Cells were then incubated
in complete medium for approximately 7 hr prior to fixation. Cells
Cell Culture, Preparation of Mitotic and Interphase Cytosol, were stained with anti-Giantin antibody to visualize Golgi mem-
and Golgi Fragmentation Assay branes, with rhodamine-conjugated anti-rabbit IgG to visualize in-
NRK cells were grown in complete medium (-MEM [GIBCO-BRL] jected cells and with Hoechst to visualize the organization of the
containing 10% FCS, 10 U/ml penicillin, and 100g/ml streptomycin) DNA. For the Golgi prefragmentation experiment, aphidicolin-
at 37C in a 5% CO2 incubator. Cytosol from NRK cells arrested arrested cells were washed with complete medium to remove
either in mitosis or in interphase, at a concentration of 12–14 mg/ aphidicolin and treated with 500 ng/ml nocodazole (Calbiochem)
ml, was prepared as described previously (Acharya et al., 1998). for 90 min prior to antibody injection. Golgi membranes were also
Permeabilization of cells grown on coverslips and the mitotic Golgi fragmented after injection of the antibody by adding 200 ng/ml BFA
fragmentation assay was performed as described (Acharya et al., (Sigma) or 500 ng/ml nocodazole 4.5 hr after aphidicolin washout.
1998). In brief, cells that have been treated with 2 mM thymidine Injection of the recombinant protein was performed in the same
for 8–14 hr were permeabilized on ice with 30 g/ml digitonin in manner as described for the antibody, except that GRASP65200
KHM buffer (25 mM HEPES-KOH [pH 7.4], 125 mM KOAc, and 2.5
(at concentration of 5 mg/ml) was coinjected with Dextran-FITC
mM MgOAc). Permeabilized cells were washed with 1 M KCl-con-
(Molecular Probes) to visualize the injected cells. Cells were stained
taining KHM and incubated with interphase or mitotic cytosol in the
with anti-GRASP65 antibody to detect injected cells and with
presence of 200 g/ml anti-GRASP65 antibody or preimmune IgG
Hoechst 33342.and an ATP-regenerating system. Incubations were carried out in
a volume of 50 l. After a 60 min incubation at 32C, cells were fixed
Staining of DNA with Bromodeoxyuridineand processed for immunofluorescence using anti-Giantin antibody
Cells were arrested with aphidicolin for 12–16 hr. At 45 min afterto visualize the structure of the Golgi or with rhodamine-conjugated
washout of aphidicolin, the cells were microinjected with the affinity-anti-rabbit IgG to follow the localization of the antibody added to
purified anti-GRASP65 antibody. Sixty minutes later, the cells werethe incubation mixture. For each experiment, 200 cells per coverslip
pulse labeled for 30 min with 15 M bromodeoxyuridine (BrdU:were analyzed for their Golgi morphology.
Calbiochem) in complete medium and fixed 7–8 hr after the initial
aphidicolin removal with 4% formaldehyde, 0.5% Triton X-100 inGeneration of Anti-GRASP65 Antibody and Antibody
PBS. The cells were washed with PBS, 0.05% Tween prior to dena-Affinity Purification
turation of the DNA with 4 M HCl for 30 min. Cells were then washedRecombinant epitope-tagged GRASP65 protein was generated as
described (Su¨tterlin et al., 2001). After the purification of 6His-tagged with 0.1 M sodium borate, PBS/Tween and processed for immuno-
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fluorescence using a monoclonal anti-BrdU antibody and an anti- cells treated with brefeldin A: evidence for membrane cycling from
Golgi to ER. Cell 56, 801–813.rabbit antibody to detect injected cells.
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